There is just no standard of care. Emily Hilliard, a spokesperson for the Department of Health and Human Services, told KFF Health News that compounded drugs should only be used in patients whose medical needs cannot be met by an FDA-approved drug. Hilliard said the agency urges consumers to be vigilant and know the source of their medicine. Understanding the risks While weight loss drugs have helped millions of people lose weight, theyre not without risk, the data show
NICE's overarching guidance on obesity management emphasises that pharmacological treatment should always be used alongside dietary, behavioural, and physical activity interventions
This isn't the day to test your tolerance with a huge meal or experiment with risky foods
Patient Experiences with Tirzepatide People who have used tirzepatide for a long time share valuable stories about how it helps them
Tesamorelin vs Sermorelin: Choosing the Right Peptide for Your Research Choose Tesamorelin When: The primary research endpoint is visceral adipose tissue (VAT) reduction Rapid, measurable IGF-1 elevation is needed within a short protocol window Studying metabolic syndrome, abdominal obesity, or lipodystrophy models Extended protocol stability is required (tesamorelin resists enzymatic degradation better) Research budget supports a higher-cost compound for a shorter, intensive protocol Choose Sermorelin When: The focus is long-term endocrine system support and hormonal homeostasis Sleep architecture and recovery pathways are the primary study variables Anti-aging, collagen synthesis, or longevity markers are being investigated A physiological, pulsatile GH release pattern is required to preserve feedback loops Cost efficiency over a long-duration protocol is a consideration The comparison extends beyond just these two peptides
Prescribed as Wegovy or Ozempic, its one of the few medicines to have predictable results, with clinical trials showing weight loss of up to 10-15% in about a year
